MiR‐3680‐3p is a novel biomarker for the diagnosis and prognosis of liver cancer and is involved in regulating the progression of liver cancer

Documenti analoghi

• Zinc finger protein 169 promotes tumor progress of hepatocellular cancer via up‐regulating cyclin‐dependent kinase 19
  di: Chaoquan Hu, et al.
  Pubblicazione: (2025)
• Particulate matters 2.5 induce tumor progression in lung cancer by increasing the activity of hnRNPA2B1 resulting in retarding mRNA decay of oxidative phosphorylation
  di: Wen Bian, et al.
  Pubblicazione: (2024)
• Overexpression of RGPR‐p117 reveals anticancer effects by regulating multiple signaling pathways in bone metastatic human breast cancer MDA‐MB‐231 cells
  di: Masayoshi Yamaguchi, et al.
  Pubblicazione: (2025)
• CDKN3 as a key regulator of G2M phase in triple‐negative breast cancer: Insights from multi‐transcriptomic analysis
  di: Haodi Ma, et al.
  Pubblicazione: (2025)
• Integrated multi‐omics and machine learning reveal a gefitinib resistance signature for prognosis and treatment response in lung adenocarcinoma
  di: Dong Zhou, et al.
  Pubblicazione: (2024)